Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Parolia

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Epigenomics|April 21, 2016
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancerFrancesco Crea, Erik Venalainen, Xinpei Ci, et al.
Scientific Reports|June 24, 2017
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancerNoushin Nabavi, Nur Ridzwan Nur Saidy, Erik Venalainen, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2021
TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral InfectionCarrie-Anne Malinczak, Abhijit Parolia, Wendy Fonseca, et al.
Journal of Medicinal Chemistry|April 30, 2024
Discovery of LLC0424 as a Potent and Selective <i>in Vivo</i> NSD2 PROTAC DegraderLianchao Liu, Abhijit Parolia, Yihan Liu, et al.
Molecular Cancer|March 7, 2015
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivoAbhijit Parolia, Francesco Crea, Hui Xue, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2023
Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomasMateus Mota, Stefan R Sweha, Matt Pun, et al.
Oncotarget|February 13, 2014
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancerFrancesco Crea, Akira Watahiki, Luca Quagliata, et al.
Nature|June 28, 2019
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancerAbhijit Parolia, Marcin Cieslik, Shih-Chun Chu, et al.
Clinical Epigenetics|February 16, 2016
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier-Luc Clermont, Francesco Crea, Yan Ting Chiang, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Epigenomics|April 21, 2016
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancerFrancesco Crea, Erik Venalainen, Xinpei Ci, et al.
Scientific Reports|June 24, 2017
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancerNoushin Nabavi, Nur Ridzwan Nur Saidy, Erik Venalainen, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2021
TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral InfectionCarrie-Anne Malinczak, Abhijit Parolia, Wendy Fonseca, et al.
Journal of Medicinal Chemistry|April 30, 2024
Discovery of LLC0424 as a Potent and Selective <i>in Vivo</i> NSD2 PROTAC DegraderLianchao Liu, Abhijit Parolia, Yihan Liu, et al.
Molecular Cancer|March 7, 2015
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivoAbhijit Parolia, Francesco Crea, Hui Xue, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2023
Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomasMateus Mota, Stefan R Sweha, Matt Pun, et al.
Oncotarget|February 13, 2014
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancerFrancesco Crea, Akira Watahiki, Luca Quagliata, et al.
Nature|June 28, 2019
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancerAbhijit Parolia, Marcin Cieslik, Shih-Chun Chu, et al.
Clinical Epigenetics|February 16, 2016
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier-Luc Clermont, Francesco Crea, Yan Ting Chiang, et al.
Pageof 6